HIGH COURT TO RULE ON DRUG COMPANIES' DUTY TO DISCLOSE ‘ADVERSE EVENTS' Matrixx Initiatives v. Siracusano | Secondary Sources | Westlaw

HIGH COURT TO RULE ON DRUG COMPANIES' DUTY TO DISCLOSE ‘ADVERSE EVENTS' Matrixx Initiatives v. Siracusano | Secondary Sources | Westlaw

View on Westlaw or start a FREE TRIAL today, HIGH COURT TO RULE ON DRUG COMPANIES' DUTY TO DISCLOSE ‘ADVERSE EVENTS' Matrixx Initiatives v. Siracusano, Secondary Sources
17 No. 3 Westlaw Journal Derivatives 19
Westlaw Journal Derivatives
*1 December 22, 2010
Securities Litigation & Regulation (Fraud)
Copyright © 2010 Thomson Reuters .

HIGH COURT TO RULE ON DRUG COMPANIES' DUTY TO DISCLOSE ‘ADVERSE EVENTS'

Matrixx Initiatives v. Siracusano

Briefs and Other Related Documents
The U.S. Supreme Court is set to hear arguments in a securities fraud case that has the pharmaceutical industry alarmed over the prospect of having to disclose to investors so-called “adverse event reports” even when those reports are statistically...
End of Document© 2024 Thomson Reuters. No claim to original U.S. Government Works.